lung Cancer Screening Market Size, Leading Players, Analysis, Sales Revenue and Forecast 2029
lung Cancer Screening Market: size was valued at USD 2.18 Billion in 2021 and the total Lung Cancer Screening revenue is expected to grow at a CAGR of 8.32% from 2022 to 2029, reaching nearly USD 4.13 Billion.
lung Cancer Screening Market Overview:
The lung Cancer Screening Market Analysis is an in-depth look at the lung Cancer Screening market, with a focus on global market trends and analysis. The purpose of this research is to provide an overview of the lung Cancer Screening industry as well as a comprehensive market analysis by segment and geography. The lung Cancer Screening market is expected to expand rapidly over the forecast period. The research contains critical information on the market positions of the top lung Cancer Screening corporations, as well as noteworthy industry trends and prospects.
Request A Free Sample Now To Gain A Better Understanding Of lung Cancer Screening Market @ https://www.maximizemarketresearch.com/request-sample/166924
lung Cancer Screening Market Dynamic:
An increased focus on research and development activities of lung cancer diagnostic and screening tests is one of the major factors driving the lung cancer screening market growth. For example, in April 2020, researchers at the Massachusetts Institute of Technology (MIT) developed a nanoparticle-based method for early lung cancer detection via a simple urine test. The method identifies biomarkers produced by peptide-coated nanoparticles interacting with disease-associated proteases in the tumor microenvironment. Experiments in two distinct lung cancer mouse models revealed that the urine test may identify tumors as tiny as 2.8 mm. The researchers expect that this noninvasive diagnosis approach would lower the number of false positives associated with a current test method and allow them to discover more cancers in the early stages of illness.
Market Scope:
The study includes a PESTLE analysis to assess the market's leading competitors' strengths and weaknesses. In order to predict the market and give investors professional insights to keep them up to speed on market developments, the research thoroughly investigates the lung Cancer Screening Market size, share, trends, total earnings, gross revenue, and profit margin.
The report also provides company biographies, product photos and specifications, capacity, production, price, cost, revenue, and contact information for the Global lung Cancer Screening market's major industry players. This study investigates market trends, volume, and value on a global, regional, and company level. This report analyses the whole lung Cancer Screening Market Size from a global perspective, analyzing historical data and creating estimates.
lung Cancer Screening Market Segmentation:
Based on Diagnosis Type, the Low Dose Spiral CT Scan segment held the largest market share of about 74% in 2021. The segment is expected to dominate the lung cancer screening market at the end of the forecast period. The favorable reimbursement regulations for cancer screening and the increasing adoption of low-dose spiral CT scan in the screening of this type of cancer is expected to drive the segment growth during the forecast period. Additionally, rising awareness regarding the mortality advantages of low-dose spiral CT scan screening is expected to influence market growth throughout the forecast period. The National Cancer Institute's Division of Cancer Prevention, for example, performed the National Lung Screening Trial at 33 screening facilities across the United States with 53,456 participants. According to the trial, screening with low-dose CT decreased mortality by 20%. Similarly, in Europe, trials such as the Dutch-Belgian Randomized Lung Cancer Screening Trial (NELSON study) and the U.K.
lung Cancer Screening Market Key Players:
• GE Healthcare (United States)
• PenRad Technologies, Inc. (United States)
• NanoString, Myriad Genetics Inc. (United States)
• OncoCyte (United States)
• Biodesix (United States)
• Broncus (United States)
• Abbott (United States)
• Illumina, Inc., (United States)
• Thermo Fischer Scientific (United States)
• Medtronic (United States)
• Nuance Communications, Inc. (United States)
• Riverain Tech (United States)
• 20/20 Gene Systems (United States)
• Danaher Corporation (United States)
• NeoGenomics (United States)
• Eon Health (United States)
• Siemens Healthineers AG (Germany)
• Agilent Technologies, Inc., AstraZeneca (United Kingdom)
• Insight Genetics (United Kingdom)
• Inivata (United Kingdom)
• Oncimmune (United Kingdom)
• Koninklijke Philips N.V. (The Netherlands)
• QIAGEN (The Netherlands)
• Quest Diagnostics Incorporated (The Netherlands)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Janssen Pharmaceuticals, Inc. (Belgium)
• Sanofi, (France)
• Canon Medical Systems Corporation (Japan)
• FUJIFILM Holdings Corporation (Japan)
• VisionGate (India)
• Integrated Diagnostics (India)
• Volpara Solutions Limited. (New Zealand)
Primary and secondary research identifies important market participants, whereas primary and secondary research calculates market revenues. In-depth interviews with important thought leaders and industry professionals, such as experienced front-line staff, CEOs, and marketing executives, were conducted as part of the core research. Primary research comprised in-depth interviews with key thought leaders and industry professionals, such as experienced front-line staff, CEOs, and marketing executives, while secondary research included a review of the main manufacturers' annual and financial reports. Secondary data is used to compute percentage splits, market shares, growth rates, and worldwide market breakdowns, which are then compared to original data. The following is a list of a few firms involved in the lung Cancer Screening industry.
lung Cancer Screening Market Regional Analysis:
The lung Cancer Screening research focuses on geographical analysis, which is further separated by sub-regions and nations. Profit projections and market share statistics for each country are included in this section of the research. This portion of the research examines the share and growth rate of each area and nation throughout the anticipated time period.
The report provides a precise PESTEL analysis for all five regions, including North America, Europe, Asia Pacific, the Middle East, Africa, and South America, after considering political, economic, social, and technical issues affecting the lung Cancer Screening market in various sectors.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) all @ https://www.maximizemarketresearch.com/request-sample/166924
COVID-19 Impact Analysis on lung Cancer Screening Market:
As a result of the COVID-19 outbreak, customer behaviour has changed in many spheres of society. In contrast, industries will need to adjust their strategy to account for shifting market supply. This study will assist you in expanding your business in compliance with the new industry standards by providing an overview of the COVID-19's impact on the lung Cancer Screening market.
The lung Cancer Screening Market Report presents 360-degree study under the COVID-19 Influence area, spanning from the flexible supply chain and import constraints to provincial government regulations and the firm's future impact. Primary market research (2021-2027), examples of venture rivalry, advantages and disadvantages of major firm streams, and industry growth trends (2021-2027) have all been provided.
Key Questions Answered in the lung Cancer Screening Market Report are:
- How big is the market for lung Cancer Screening?
- Which regional market will emerge as the market leader in the next years?
- Which application category is expected to develop the fastest?
- What opportunities for growth may exist in the lung Cancer Screening industry in the next years?
- What are the most significant future challenges that the lung Cancer Screening market may face?
- Who are the market leaders in the lung Cancer Screening category?
- What are the main trends that are influencing market growth?
About Us
Maximize Market Research provides B2B and B2C research on 12,500 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact Us:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT Park Phase 2,
Pune Banglore Highway,
Narhe, Pune, Maharashtra 411041, India.
Email: sales@maximizemarketresearch.com
Phone No.: +91 9607365656
Website: www.maximizemarketresearch.com
More Trending Report:
Procurement-as-a-Service Market: https://www.maximizemarketresearch.com/market-report/procurement-as-a-service-market/165074/
Intraoral Scanners market: https://www.maximizemarketresearch.com/market-report/intraoral-scanners-market/165094/